USING A MEDICAL PRESCRIPTION IN ANOTHER EUROPEAN UNION COUNTRY Practical and Legal Guide – 2026 Update By DrRamonReyesMD ⚕️

 

USING A MEDICAL PRESCRIPTION IN ANOTHER EUROPEAN UNION COUNTRY
Practical and Legal Guide – 2026 Update
By DrRamonReyesMD ⚕️
EMS Solutions International
https://emssolutionsint.blogspot.com

INTRODUCTION

A medical prescription issued by a licensed healthcare professional in one European Union (EU) Member State can generally be recognized and used in another EU Member State, provided that it contains the information required under European legislation.

This mechanism is known as a cross-border prescription and is intended to facilitate continuity of care for patients traveling, working, studying, or residing temporarily within the European Union.

Importantly, there is no mandatory European prescription template. What matters is that the prescription contains all legally required information.

---

MANDATORY INFORMATION FOR A CROSS-BORDER PRESCRIPTION

A prescription intended for use in another EU country should contain at least the following information:

Patient Information

• Full surname(s)
• Full given name(s)
• Date of birth

Prescription Information

• Date of issue

Prescriber's Information

• Full surname(s)
• Full given name(s)
• Professional qualification
• Direct contact details
• Professional address, including country
• Handwritten or qualified digital signature

Prescribed Medication Information

• International Nonproprietary Name (INN) or generic name whenever possible
• Pharmaceutical form (tablet, capsule, solution, injection, cream, eye drops, etc.)
• Strength/concentration
• Quantity prescribed
• Dosage instructions
• Route of administration
• Duration of treatment when appropriate

Example:

METFORMIN 850 MG TABLETS
TAKE ONE TABLET ORALLY EVERY 12 HOURS
QUANTITY: 60 TABLETS

---

WHY GENERIC NAMES ARE IMPORTANT

Brand names vary significantly across Europe.

A medication marketed under one commercial name in Spain may be sold under a completely different name in France, Germany, Portugal, Italy, or other EU countries.

For this reason, European legislation strongly recommends prescribing using the generic (INN) name whenever clinically appropriate.

Example:

Preferred:

IBUPROFEN 600 MG TABLETS

Less useful:

Local brand name that may not exist abroad.

Using the generic name allows pharmacists in another country to identify an equivalent authorized product more easily.

---

IMPORTANT LIMITATIONS

Although a prescription may be legally recognized throughout the EU, the dispensing process is governed by the laws of the country where the medicine is supplied.

This means that local pharmacy regulations determine:

• Prescription validity period
• Maximum quantity that may be dispensed
• Availability of the medicine
• Rules regarding substitution
• Controlled substances restrictions
• Narcotic and psychotropic medication regulations
• Reimbursement eligibility

Therefore, a prescription valid in Spain may still be subject to different dispensing conditions in France, Germany, Belgium, Portugal, or any other EU country.

---

ELECTRONIC PRESCRIPTIONS

Electronic prescriptions are not yet universally interoperable across Europe.

Patients traveling abroad should request a paper copy whenever possible, even if their home country routinely uses electronic prescribing systems.

The European Union is progressively implementing interoperability through the MyHealth@EU infrastructure, which supports:

• ePrescription
• eDispensation
• Patient Summary exchange

However, availability depends on the participating countries and the maturity of their national digital health systems.

---

PRACTICAL ADVICE FOR PHYSICIANS

When issuing a prescription for a patient who will travel abroad, it is advisable to include:

• Complete patient identification
• Generic drug name (INN)
• Exact dosage
• Pharmaceutical form
• Total quantity
• Clear administration instructions
• Treatment duration
• Full professional details
• Professional telephone number or email
• Professional address including country
• Signature

Doing so significantly reduces the risk of difficulties at foreign pharmacies.

---

PRACTICAL ADVICE FOR PATIENTS

Before traveling:

• Carry a paper prescription even if you use e-prescriptions at home.
• Bring sufficient medication for the first days of travel.
• Keep medicines in their original packaging.
• Carry a medical report for chronic diseases.
• Carry supporting documentation for insulin, anticoagulants, injectable therapies, opioids, and psychotropic medications.
• Verify medication availability in the destination country whenever possible.

---

EUROPEAN ECONOMIC AREA AND SWITZERLAND

The cross-border prescription framework applies not only to the European Union but also to:

• Norway
• Iceland
• Liechtenstein

These countries participate through the European Economic Area (EEA).

Switzerland is not part of the EU cross-border prescription recognition framework and is not legally obliged to accept EU prescriptions. Likewise, EU Member States are not required to recognize Swiss prescriptions under these rules.

---

LEGAL FRAMEWORK

Directive 2011/24/EU

Directive 2011/24/EU of the European Parliament and of the Council on the application of patients' rights in cross-border healthcare.

URL: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32011L0024

Commission Implementing Directive 2012/52/EU

Commission Implementing Directive 2012/52/EU establishing measures to facilitate the recognition of medical prescriptions issued in another Member State.

URL: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32012L0052

Spanish Royal Decree 81/2014

Royal Decree 81/2014 implementing cross-border healthcare rules in Spain.

URL: https://www.boe.es/buscar/act.php?id=BOE-A-2014-1331

European Commission – Prescriptions Abroad

URL: https://europa.eu/youreurope/citizens/health/prescription-medicine-abroad/prescriptions/index_en.htm

European Commission – MyHealth@EU

URL: https://health.ec.europa.eu/ehealth-digital-health-and-care/digital-health-and-care/electronic-cross-border-health-services_en

---

SCIENTIFIC REFERENCE

Bruthans J, Jiráková K.

The Current State and Usage of European Electronic Cross-border Health Services (eHDSI).

Journal of Medical Systems. 2023;47:21.

DOI: 10.1007/s10916-023-01920-9

URL: https://link.springer.com/article/10.1007/s10916-023-01920-9

---

CONCLUSION

A European cross-border prescription is not defined by a special format but by the information it contains.

When properly completed, it allows patients to obtain prescribed medicines throughout the European Union and the European Economic Area, helping ensure continuity of care during travel, work assignments, study programs, or temporary residence abroad.

The safest approach remains straightforward:

Prescribe by generic name, provide complete patient and prescriber identification, include clear dosing instructions, and carry a paper copy whenever traveling internationally.